These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 9950963

  • 21. Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats.
    Opocenský M, Dvorák P, Malý J, Kramer HJ, Bäcker A, Kopkan L, Vernerová Z, Tesar V, Zima T, Bader M, Ganten D, Janda J, Vanecková I.
    Physiol Res; 2004; 53(6):581-93. PubMed ID: 15588125
    [Abstract] [Full Text] [Related]

  • 22. Increased pressor function of central vasopressinergic system in hypertensive renin transgenic rats.
    Szczepańska-Sadowska E, Paczwa P, Loń S, Ganten D.
    J Hypertens; 1998 Oct; 16(10):1505-14. PubMed ID: 9814623
    [Abstract] [Full Text] [Related]

  • 23. Angiotensin peptides acting at rostral ventrolateral medulla contribute to hypertension of TGR(mREN2)27 rats.
    Fontes MA, Baltatu O, Caligiorne SM, Campagnole-Santos MJ, Ganten D, Bader M, Santos RA.
    Physiol Genomics; 2000 Apr 27; 2(3):137-42. PubMed ID: 11015592
    [Abstract] [Full Text] [Related]

  • 24. Transgenic hypertensive rats show a reduced angiotensin II induced [Ca2+]i response in glomerular mesangial cells.
    Tepel M, Heidenreich S, Zidek W.
    Life Sci; 1998 Apr 27; 62(1):69-76. PubMed ID: 9444969
    [Abstract] [Full Text] [Related]

  • 25. Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system.
    Varcabova S, Huskova Z, Kramer HJ, Hwang SH, Hammock BD, Imig JD, Kitada K, Cervenka L.
    Clin Exp Pharmacol Physiol; 2013 Apr 27; 40(4):273-81. PubMed ID: 23039246
    [Abstract] [Full Text] [Related]

  • 26. NO-independent mechanism mediates tempol-induced renal vasodilation in SHR.
    de Richelieu LT, Sorensen CM, Holstein-Rathlou NH, Salomonsson M.
    Am J Physiol Renal Physiol; 2005 Dec 27; 289(6):F1227-34. PubMed ID: 16033921
    [Abstract] [Full Text] [Related]

  • 27. Interactive effects of superoxide anion and nitric oxide on blood pressure and renal hemodynamics in transgenic rats with inducible malignant hypertension.
    Patterson ME, Mouton CR, Mullins JJ, Mitchell KD.
    Am J Physiol Renal Physiol; 2005 Oct 27; 289(4):F754-9. PubMed ID: 15900020
    [Abstract] [Full Text] [Related]

  • 28. Effects of long-term intrarenal angiotensin II infusion on renal vascular responsiveness to vasoactive agents.
    Fitzgerald SM, Stevenson KM, Evans RG, Anderson WP.
    Clin Exp Pharmacol Physiol; 1998 Oct 27; 25(7-8):633-6. PubMed ID: 9673443
    [Abstract] [Full Text] [Related]

  • 29. Effects of sodium restriction and cyclooxygenase-2 inhibition on the course of hypertension, proteinuria and cardiac hypertrophy in Ren-2 transgenic rats.
    Vanecková I, Skaroupková P, Dvorák P, Certíková Chábová V, Tesar V, Bader M, Ganten D, Kramer HJ.
    Physiol Res; 2005 Oct 27; 54(1):17-24. PubMed ID: 15717837
    [Abstract] [Full Text] [Related]

  • 30. Exaggerated natriuresis in transgenic (mRen2)27 rats.
    Schneider K, Gross V, Lippoldt A, Luft FC.
    J Hypertens; 1997 Sep 27; 15(9):1041-8. PubMed ID: 9321753
    [Abstract] [Full Text] [Related]

  • 31. Endothelial vasoconstrictor prostanoids modulate contractions to acetylcholine and ANG II in Ren-2 rats.
    Noll G, Lang MG, Tschudi MR, Ganten D, Lüscher TF.
    Am J Physiol; 1997 Jan 27; 272(1 Pt 2):H493-500. PubMed ID: 9038972
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
    Handa RK, Strandhoy JW, Handa SE.
    Kidney Blood Press Res; 2003 Jan 27; 26(3):165-75. PubMed ID: 12886044
    [Abstract] [Full Text] [Related]

  • 35. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
    Tokita Y, Franco-Saenz R, Mulrow PJ.
    Am J Hypertens; 1995 Oct 27; 8(10 Pt 1):1031-9. PubMed ID: 8845072
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Interactions between renal vascular resistance and endothelium-derived hyperpolarization in hypertensive rats in vivo.
    Stannov SU, Brasen JC, Salomonsson M, Holstein-Rathlou NH, Sorensen CM.
    Physiol Rep; 2019 Aug 27; 7(15):e14168. PubMed ID: 31368238
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.